The Latest Breaking News from ALT

From sourdough pizza crusts to reconstructed chocolate bars, Alt.Pizza, the Singapore-based pizza chain, offers an alternate take on fan favourites in its Bengaluru outlet

alt_ (you can call them “Alt Space”) plans to put the money to work on education and beautification projects, among other things.

The U.S. Food and Drug Administration (FDA) has granted fast track designation for the development of TRACON’s (NASDAQ:TCON) lead asset envafolimab (KN035) for patients with locally advanced, unresectable or metastatic undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS) who have progressed on one or two prior lines of chemotherapy. TRACON shares…

U.S. stocks pared gains toward the end of trading, with the Dow Jones dropping around 80 points on Wednesday.

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

CLARE Grogan was starring in Neil Simon’s rom-com Barefoot In the Park at the 2020 Pitlochry Festival Theatre when lockdown kicked in.

NEW DELHI

  Altimmune (NASDAQ:ALT) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

According to Benzinga Pro data, during Q4, Altimmune (NASDAQ:ALT) posted sales of $3.28 million. Earnings were up 28.71%, but Altimmune still reported an overall loss of $23.89 million.

  Altimmune (NASDAQ:ALT) reported its Q4 earnings results on Tuesday, March 15, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Altimmune (NASDAQ:ALT) is set to give its latest quarterly earnings report on Monday, 2022-03-14. Here's what investors need to know before the announcement. Analysts estimate that Altimmune will report an earnings per share (EPS) of $-0.65.